TIMOLSIGN Eye Drops are a therapeutic ophthalmic solution formulated with Timolol Maleate, a non-selective beta-adrenergic antagonist widely used in the treatment of elevated intraocular pressure (IOP) associated with open-angle glaucoma and ocular hypertension. This medication plays a crucial role in glaucoma management, helping prevent optic nerve damage and the subsequent risk of vision loss by maintaining stable eye pressure.
Timolol Maleate works by reducing the production of aqueous humor, the fluid responsible for maintaining intraocular pressure. By inhibiting beta-adrenergic receptor activity in the ciliary body of the eye, TIMOLSIGN Eye Drops effectively reduce fluid secretion without affecting the outflow pathways. This makes it especially useful in conditions where excessive aqueous humor production leads to damaging pressure buildup within the eye. The clinical efficacy of timolol has been extensively documented, making it a cornerstone in glaucoma pharmacotherapy.
Administered as sterile eye drops, TIMOLSIGN is typically used once or twice daily, depending on the severity of the condition and the patient's response. The ophthalmic solution is clear and colorless, with each mL typically containing 0.5% or 0.25% Timolol Maleate, as per formulation requirements. The dosage may vary, and adjustment is guided by regular IOP measurements and ophthalmic evaluations. TIMOLSIGN can be used alone or in combination with other IOP-lowering agents such as prostaglandin analogs, carbonic anhydrase inhibitors, or alpha agonists for enhanced therapeutic outcomes.
TIMOLSIGN Eye Drops are generally well-tolerated. However, as with all beta-blockers, systemic absorption may occur and can lead to side effects in susceptible individuals, particularly those with asthma, chronic obstructive pulmonary disease, bradycardia, or heart block. Therefore, care must be taken when prescribing to patients with underlying respiratory or cardiac conditions. Ocular side effects are typically minimal and may include temporary eye irritation, blurred vision, or dry eyes. Patient counseling regarding the nasolacrimal occlusion technique can help minimize systemic absorption and associated adverse effects.
Manufactured under BluepillExpress, TIMOLSIGN Eye Drops adhere to strict quality control and assurance protocols, ensuring sterility, efficacy, and chemical stability. Production takes place in GMP-certified sterile facilities, with every batch subjected to rigorous microbiological and physicochemical testing. The packaging is compliant with international standards for ophthalmic products, including tamper-evident seals, clear labeling, and preservative-free variants if required. BluepillExpress offers this product in various fill volumes such as 5 mL or 10 mL plastic dropper bottles, with options for low-density polyethylene (LDPE) or high-barrier materials for enhanced shelf life.
TIMOLSIGN Eye Drops are an ideal offering for third-party manufacturing and export. BluepillExpress supports global partners with all necessary regulatory documentation, including Certificate of Analysis (CoA), Product Dossier (CTD format), and stability data for climatic zones III and IV. The product is suitable for export to both regulated and semi-regulated markets. Custom branding and private labeling services are also available, enabling clients to build their ophthalmic portfolios with high-quality, cost-effective products.
Given the global rise in glaucoma prevalence, especially among the aging population, TIMOLSIGN Eye Drops represent a vital therapeutic solution with strong market potential. As glaucoma is typically asymptomatic in the early stages, early intervention with effective medications like TIMOLSIGN is critical. Its inclusion in national and international treatment guidelines reflects the importance and widespread use of Timolol in maintaining visual health and preventing blindness.
In conclusion, TIMOLSIGN Eye Drops from BluepillExpress offer a clinically proven, safe, and effective option for the management of elevated intraocular pressure. With a focus on pharmaceutical excellence, regulatory compliance, and international standards, BluepillExpress empowers healthcare brands and distributors to deliver trusted ophthalmic care solutions to their markets. TIMOLSIGN is more than a medication—it is a commitment to preserving vision and improving patient quality of life across the globe.
Description provided by Bluepill Express.
Timolol Maleate (0.25% or 0.5%)
Treatment of elevated intraocular pressure in ocular hypertension and open-angle glaucoma
Non-selective beta-adrenergic receptor blocker reducing aqueous humor production
Sterile ophthalmic solution, clear and colorless eye drops
Once or twice daily, as per physician’s prescription
5 mL or 10 mL plastic dropper bottles with LDPE or high-barrier materials
GMP-certified sterile production with rigorous quality control
Can be used alone or combined with prostaglandin analogs, carbonic anhydrase inhibitors, alpha agonists
Minimal ocular irritation; caution in respiratory/cardiac conditions
Full documentation support including CoA, CTD dossier, stability data for export
Specifications
Concentration Strengths
0.25% and 0.5% Timolol Maleate
Formulation Type
Preservative-free options available
Bottle Material
Low-Density Polyethylene (LDPE) or high-barrier plastic
Volume
Available in 5 mL and 10 mL sizes
Storage Conditions
Store below 30°C in a cool, dry place; protect from light
Shelf Life
Minimum 24 months (subject to regulatory approval)
Sterility Assurance
Manufactured in GMP-certified sterile environment with microbiological testing
Preservative
Available with or without preservatives based on client specifications
Suitable Patient Groups
Adults with ocular hypertension or open-angle glaucoma
Pharmacological Class
Beta-adrenergic receptor blocker (beta-blocker)
FIEO Registered
Export Ready
